These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17659816)

  • 21. Vaccination with Mycobacterium bovis BCG strains Danish and Pasteur in white-tailed deer (Odocoileus virginianus) experimentally challenged with Mycobacterium bovis.
    Palmer MV; Thacker TC; Waters WR
    Zoonoses Public Health; 2009 Jun; 56(5):243-51. PubMed ID: 19175569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.
    Ritz N; Tebruegge M; Connell TG; Sievers A; Robins-Browne R; Curtis N
    Antimicrob Agents Chemother; 2009 Jan; 53(1):316-8. PubMed ID: 18955515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comment on Hesseling, et al. "The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children" [Vaccine 25 (2006) 14-18].
    Taştan Y
    Vaccine; 2007 Jun; 25(23):4513. PubMed ID: 17434241
    [No Abstract]   [Full Text] [Related]  

  • 24. Development of a Mycobacterium bovis intranasal challenge model in mice.
    Logan KE; Gavier-Widen D; Hewinson RG; Hogarth PJ
    Tuberculosis (Edinb); 2008 Sep; 88(5):437-43. PubMed ID: 18590980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Consequence of prior exposure to environmental mycobacteria on BCG vaccination and diagnosis of tuberculosis infection.
    Thom M; Howard C; Villarreal-Ramos B; Mead E; Vordermeier M; Hope J
    Tuberculosis (Edinb); 2008 Jul; 88(4):324-34. PubMed ID: 18329343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of cell-mediated immune response in mice by whole HIV-1 gag in Mycobacterium bovis BCG as a live vaccine candidate.
    Promkhatkaew D; Pinyosukhee N; Thongdeejaroen W; Sutthent R; Sawanpanyalert P; Warachit P
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):113-22. PubMed ID: 19323043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnosis of postvaccinal complications after administration of BCG vaccine. (Methodical recommendations No. 99/219].
    Health Ministry of the Russian Federation, Moscow. Moscow 2000
    Probl Tuberk; 2002; (6):53-6. PubMed ID: 12227058
    [No Abstract]   [Full Text] [Related]  

  • 28. BCG vaccination: a long-lasting protection against tuberculosis?
    Hernández-Garduño E
    Lancet Infect Dis; 2016 Apr; 16(4):408. PubMed ID: 27036343
    [No Abstract]   [Full Text] [Related]  

  • 29. BCG vaccination in children.
    BMJ; 1990 Dec; 301(6763):1274-5. PubMed ID: 2091641
    [No Abstract]   [Full Text] [Related]  

  • 30. Mycobacterium avium subsp. paratuberculosis-specific mpt operon expressed in M. bovis BCG as vaccine candidate.
    Heinzmann J; Wilkens M; Dohmann K; Gerlach GF
    Vet Microbiol; 2008 Aug; 130(3-4):330-7. PubMed ID: 18343053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term protectiveness of BCG.
    Sotgiu G; Migliori GB
    Lancet Infect Dis; 2016 Feb; 16(2):140-2. PubMed ID: 26603175
    [No Abstract]   [Full Text] [Related]  

  • 32. BCG vaccine. WHO position paper.
    World Health Organization
    Wkly Epidemiol Rec; 2004 Jan; 79(4):27-38. PubMed ID: 14768305
    [No Abstract]   [Full Text] [Related]  

  • 33. The challenges of an HIV vaccine enterprise.
    Zinkernagel RM
    Science; 2004 Feb; 303(5662):1294-7; author reply 1294-7. PubMed ID: 14988536
    [No Abstract]   [Full Text] [Related]  

  • 34. [L-forms of BCG Mycobacteria and their capacity to induce morphological reactions inherent in the BCG vaccine].
    Shmelev NA; Dorozhkova IR; Zemskova ZS
    Probl Tuberk; 1974; (1):62-70. PubMed ID: 4617227
    [No Abstract]   [Full Text] [Related]  

  • 35. BCG vaccination in children born to HIV-positive mothers.
    Matondo P
    Lancet; 1992 Sep; 340(8822):800. PubMed ID: 1356222
    [No Abstract]   [Full Text] [Related]  

  • 36. A plea for the use of BCG vaccine against tuberculosis in the United States.
    Rosenthal SR
    Med Times; 1978 Jul; 106(7):2d (88)-(88)-7d. PubMed ID: 353438
    [No Abstract]   [Full Text] [Related]  

  • 37. BCG immunization and paediatric HIV infection.
    Wkly Epidemiol Rec; 1992 May; 67(18):129-32. PubMed ID: 1581177
    [No Abstract]   [Full Text] [Related]  

  • 38. BCG vaccination: a long-lasting protection against tuberculosis?--Authors' reply.
    Nguipdop-Djomo P; Heldal E; Rodrigues LC; Abubakar I; Mangtani P
    Lancet Infect Dis; 2016 Apr; 16(4):408-9. PubMed ID: 27036342
    [No Abstract]   [Full Text] [Related]  

  • 39. Failure of a Mycobacterium tuberculosis DeltaRD1 DeltapanCD double deletion mutant in a neonatal calf aerosol M. bovis challenge model: comparisons to responses elicited by M. bovis bacille Calmette Guerin.
    Waters WR; Palmer MV; Nonnecke BJ; Thacker TC; Scherer CF; Estes DM; Jacobs WR; Glatman-Freedman A; Larsen MH
    Vaccine; 2007 Nov; 25(45):7832-40. PubMed ID: 17931755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neonatal vaccination with Mycobacterium bovis BCG: potential effects as a priming agent shown in a heterologous prime-boost immunization protocol.
    Rahman MJ; Fernández C
    Vaccine; 2009 Jun; 27(30):4038-46. PubMed ID: 19379788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.